JNCE

Jounce Therapeutics, Inc. Common Stock
JNCE

Overview Fund Activity
Delisted

JNCE was delisted on the 3rd of May, 2023.

Back to rankings

124 hedge funds and large institutions have $378M invested in Jounce Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 32 increasing their positions, 32 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
124
Holders Change
+20
Holders Change %
+19.23%
% of All Funds
2.18%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
40
Increased
32
Reduced
32
Closed
20
Calls
$596K
Puts
$3.22M
Net Calls
-$2.63M
Net Calls Change
-$2.25M

Top Buyers

1
PHS
1
PFM Health Sciences
California
$33.5M
2
Victory Capital Management
2
Victory Capital Management
Texas
$24.1M
3
O
3
OrbiMed
New York
$18.7M
4
CCM
4
CAAS Capital Management
New York
$10.8M
5
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$24.9M

Top Sellers

1
TGI
1
TRV GP II
Massachusetts
$66.8M
2
WP
2
Woodline Partners
California
$0
3
SI
3
Sofinnova Investments
California
$5.26M
4
Bank of Montreal
4
Bank of Montreal
Ontario, Canada
$111K
5
Verition Fund Management
5
Verition Fund Management
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Wells Fargo
26
Wells Fargo
California
$2.5M +$1.34M +130,366 +116%
SSA
27
Schonfeld Strategic Advisors
New York
$2.14M +$2.14M +208,812 New
HM
28
HealthCor Management
New York
$2.08M +$2.08M +202,585 New
Charles Schwab
29
Charles Schwab
California
$2.06M -$560K -54,500 -21%
Millennium Management
30
Millennium Management
New York
$1.83M +$1.34M +130,333 +272%
JPMorgan Chase & Co
31
JPMorgan Chase & Co
New York
$1.7M +$447K +43,486 +36%
Goldman Sachs
32
Goldman Sachs
New York
$1.55M +$1.19M +115,764 +326%
Mariner
33
Mariner
Kansas
$1.53M – – –
AQR Capital Management
34
AQR Capital Management
Connecticut
$1.52M -$497K -48,363 -25%
T. Rowe Price Associates
35
T. Rowe Price Associates
Maryland
$1.44M +$366K +35,630 +34%
Jacobs Levy Equity Management
36
Jacobs Levy Equity Management
New Jersey
$1.31M +$280K +27,242 +27%
Nuveen Asset Management
37
Nuveen Asset Management
Illinois
$1.29M +$13.2K +1,290 +1%
CAM
38
Congress Asset Management
Massachusetts
$1.06M +$107K +10,420 +11%
Two Sigma Investments
39
Two Sigma Investments
New York
$974K +$974K +94,849 New
Marshall Wace
40
Marshall Wace
United Kingdom
$973K +$973K +94,739 New
Connor, Clark & Lunn Investment Management (CC&L)
41
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$875K -$100K -9,734 -10%
Two Sigma Advisers
42
Two Sigma Advisers
New York
$850K +$850K +82,800 New
Bank of New York Mellon
43
Bank of New York Mellon
New York
$731K -$8.93K -869 -1%
MS
44
Maven Securities
Jersey
$707K +$707K +70,396 New
Axa
45
Axa
France
$696K +$148K +14,400 +27%
First Trust Advisors
46
First Trust Advisors
Illinois
$613K +$187K +18,246 +44%
AllianceBernstein
47
AllianceBernstein
Tennessee
$574K – – –
AI
48
Atom Investors
Texas
$562K +$562K +54,762 New
State of Wisconsin Investment Board
49
State of Wisconsin Investment Board
Wisconsin
$538K -$180K -17,500 -25%
YMRC
50
Yorktown Management & Research Company
Virginia
$505K – – –
1
2
3 4 5